asendusraviga

Asendusravi is a term used in Estonia to describe substitution therapy. It is a medical treatment approach where a prescribed medication is used to replace a substance that a person's body is not producing adequately or is lacking. This therapy is most commonly associated with the treatment of opioid addiction, where opioid agonists such as methadone or buprenorphine are used to manage withdrawal symptoms and reduce cravings. The goal is to stabilize the individual, allowing them to engage in counseling and other support services.

The use of asendusravi is based on the principle of harm reduction. By providing a legal, controlled, and medically supervised alternative to illicit drugs, it aims to reduce the risks associated with drug use, such as overdose, transmission of infectious diseases through needle sharing, and criminal activity. It is considered an effective component of a comprehensive addiction treatment program, often combined with psychosocial interventions.

In Estonia, asendusravi programs are regulated by the Ministry of Social Affairs and are typically administered by healthcare professionals in specialized clinics or health centers. Eligibility criteria and treatment protocols are established to ensure patient safety and treatment efficacy. The availability and scope of asendusravi services can vary, but the overarching objective remains to improve the health and social functioning of individuals struggling with substance use disorders.